Harold Jacob - Dec 29, 2021 Form 4 Insider Report for NanoVibronix, Inc. (NAOV)

Role: Chief Medical Officer, Director
Signature: /s/ Harold Jacob, MD
Stock symbol: NAOV
Transactions as of: Dec 29, 2021
Transactions value $: $0
Form type: 4
Date filed: 1/3/2022, 12:52 PM
Next filing: Dec 4, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NAOV	Option to Purchase Common Stock	Award	$0	+50K		$0.00	50K	Dec 29, 2021	Common Stock	50K	$1.01	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	25% of the option vested on December 29, 2021 (the "Date of Grant"), with an additional 25% to vest on the three-month anniversary of the Date of Grant, a further 25% to vest on the six-month anniversary of the Date of Grant, and the final 25% to vest on the nine-month anniversary of the Date of Grant, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan.

Content

25% of the option vested on December 29, 2021 (the "Date of Grant"), with an additional 25% to vest on the three-month anniversary of the Date of Grant, a further 25% to vest on the six-month anniversary of the Date of Grant, and the final 25% to vest on the nine-month anniversary of the Date of Grant, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan.